Farmers & Merchants Trust Co of Chambersburg PA raised its position in shares of CVS Health Corp (NYSE:CVS) by 1.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,997 shares of the pharmacy operator’s stock after buying an additional 212 shares during the quarter. Farmers & Merchants Trust Co of Chambersburg PA’s holdings in CVS Health were worth $1,114,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Daiwa SB Investments Ltd. bought a new position in shares of CVS Health during the fourth quarter valued at $30,000. Cornerstone Advisors Inc. increased its holdings in shares of CVS Health by 71.6% during the third quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock valued at $40,000 after acquiring an additional 212 shares in the last quarter. Truewealth LLC increased its holdings in shares of CVS Health by 78.6% during the fourth quarter. Truewealth LLC now owns 1,004 shares of the pharmacy operator’s stock valued at $66,000 after acquiring an additional 442 shares in the last quarter. Vigilant Capital Management LLC bought a new position in shares of CVS Health during the fourth quarter valued at $71,000. Finally, First Command Bank increased its holdings in shares of CVS Health by 22.4% during the fourth quarter. First Command Bank now owns 1,262 shares of the pharmacy operator’s stock valued at $83,000 after acquiring an additional 231 shares in the last quarter. 84.48% of the stock is owned by institutional investors and hedge funds.

Several equities analysts have recently weighed in on the company. Barclays assumed coverage on CVS Health in a report on Tuesday, December 18th. They set an “overweight” rating and a $91.00 price target for the company. Leerink Swann began coverage on CVS Health in a report on Tuesday, December 11th. They set an “outperform” rating for the company. Goldman Sachs Group reiterated a “neutral” rating and issued a $87.00 price objective on shares of CVS Health in a report on Thursday, November 29th. Argus lifted their price objective on CVS Health to $100.00 and gave the stock a “buy” rating in a report on Tuesday, November 13th. Finally, ValuEngine upgraded CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, October 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $91.44.

In other CVS Health news, EVP Troyen A. Brennan sold 14,229 shares of the business’s stock in a transaction dated Wednesday, November 14th. The stock was sold at an average price of $82.00, for a total transaction of $1,166,778.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Larry J. Merlo sold 166,368 shares of the business’s stock in a transaction dated Tuesday, January 8th. The shares were sold at an average price of $69.04, for a total value of $11,486,046.72. Following the sale, the insider now owns 496,577 shares of the company’s stock, valued at $34,283,676.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 205,756 shares of company stock valued at $14,668,815. Corporate insiders own 0.53% of the company’s stock.

NYSE CVS opened at $65.24 on Tuesday. CVS Health Corp has a one year low of $60.14 and a one year high of $83.88. The stock has a market capitalization of $66.68 billion, a P/E ratio of 11.06, a price-to-earnings-growth ratio of 0.88 and a beta of 1.12. The company has a quick ratio of 1.94, a current ratio of 2.44 and a debt-to-equity ratio of 1.66.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, November 6th. The pharmacy operator reported $1.73 EPS for the quarter, topping the consensus estimate of $1.71 by $0.02. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The company had revenue of $47.27 billion during the quarter, compared to the consensus estimate of $47.22 billion. During the same period last year, the company earned $1.50 EPS. CVS Health’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, sell-side analysts expect that CVS Health Corp will post 7.02 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, February 4th. Shareholders of record on Friday, January 25th will be paid a dividend of $0.50 per share. The ex-dividend date is Thursday, January 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.07%. CVS Health’s dividend payout ratio is currently 33.90%.

ILLEGAL ACTIVITY NOTICE: “Farmers & Merchants Trust Co of Chambersburg PA Purchases 212 Shares of CVS Health Corp (CVS)” was posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.watchlistnews.com/farmers-merchants-trust-co-of-chambersburg-pa-purchases-212-shares-of-cvs-health-corp-cvs/2778729.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Further Reading: How to Trade Using Analysts Ratings

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.